tiprankstipranks
Alphamab Oncology (HK:9966)
:9966
Hong Kong Market

Alphamab Oncology (9966) Financial Statements

Compare
1 Followers

Alphamab Oncology Financial Overview

Alphamab Oncology's market cap is currently HK$4.78B. The company's EPS TTM is HK$-0.241; its P/E ratio is ―; Alphamab Oncology is scheduled to report earnings on March 28, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue¥ 218.77M¥ 166.84M¥ 146.02M¥ 0.00¥ 4.99M
Gross Profit¥ 163.54M¥ 122.64M¥ 142.99M¥ 0.00¥ 4.99M
Operating Income¥ -305.55M¥ -432.37M¥ -415.62M¥ -409.45M¥ -829.13M
EBITDA¥ -129.30M¥ -391.83M¥ -358.13M¥ -390.47M¥ -277.57M
Net Income¥ -210.59M¥ -325.72M¥ -412.42M¥ -427.77M¥ -836.35M
Balance Sheet
Cash & Short-Term Investments¥ 1.41B¥ 1.35B¥ 1.99B¥ 2.06B¥ 2.38B
Total Assets¥ 2.14B¥ 2.12B¥ 2.71B¥ 2.64B¥ 2.85B
Total Debt¥ 257.08M¥ 345.39M¥ 637.27M¥ 222.81M¥ 253.18M
Net Debt¥ -828.91M¥ -723.80M¥ -166.04M¥ 37.48M¥ -1.61B
Total Liabilities¥ 465.00M¥ 559.86M¥ 834.80M¥ 366.44M¥ 428.66M
Stockholders' Equity¥ 1.67B¥ 1.56B¥ 1.87B¥ 2.27B¥ 2.43B
Cash Flow
Free Cash Flow¥ -239.02M¥ -429.96M¥ -478.72M¥ -438.00M¥ -396.87M
Operating Cash Flow¥ -202.84M¥ -300.31M¥ -320.60M¥ -347.18M¥ -225.50M
Investing Cash Flow¥ -18.11M¥ 850.76M¥ 574.26M¥ -1.52B¥ -654.01M
Financing Cash Flow¥ 218.07M¥ -310.90M¥ 363.90M¥ 186.58M¥ 2.11B
Currency in CNY

Alphamab Oncology Earnings and Revenue History

Alphamab Oncology Debt to Assets

Alphamab Oncology Cash Flow

Alphamab Oncology Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis